{"disease":{"id":"focal-onset-epilepsy","name":"focal onset epilepsy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05747001","title":"This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK","phase":"","overall_status":"COMPLETED","enrollment_count":319,"lead_sponsor_name":"Aziende Chimiche Riunite Angelini Francesco S.p.A","has_results":false},{"nct_id":"NCT05159908","title":"A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Neurocrine Biosciences","has_results":false},{"nct_id":"NCT05493293","title":"Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Neurocrine Biosciences","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}